NewsBenzingaBTIGはCullinan Therapeuticsに買いを繰り返し、価格目標を40ドルに維持します。 BTIGはCullinan Therapeuticsに買いを繰り返し、価格目標を40ドルに維持します。 Benzinga 2026.09.25 09:49 (GMT+0) Open on Benzinga Other news Airbnb Co-Founder Joe Gebbia Says He Modernized Federal Retirement System In 6 Months for $1.5 Million After Contractors Spent $100 Million NVIDIA's Jensen Huang Crisis Threatens to Rewrite the Rules of the AI Boom Mondelez's Multi-Million Portfolio Shift: Unloads French Bakery and Cereal Bars Business Ur-Energy Begins Fieldwork For Baseline Studies At Its Lost Solider Project; Will Take Construction Decision For Potential Third Mine After Technical Report Alibaba Is Facing a Perfect Storm, and Q2 Earnings Won’t Be a Magical Fix for BABA Stock CME Stock: Is Wall Street Bullish or Bearish?
Airbnb Co-Founder Joe Gebbia Says He Modernized Federal Retirement System In 6 Months for $1.5 Million After Contractors Spent $100 Million
Ur-Energy Begins Fieldwork For Baseline Studies At Its Lost Solider Project; Will Take Construction Decision For Potential Third Mine After Technical Report